JANICE MCCLUNE: Open Payments
NPI 1487019170 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,513 in 107 payments from 49 companies in 2025. Trend: 2023 $75 · 2024 $943 · 2025 $2,513
Food & beverage: $2,413Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $221 |
| Janssen Biotech, Inc. | 10 | $195 |
| Daiichi Sankyo Inc. | 7 | $163 |
| ABBVIE INC. | 8 | $151 |
| AstraZeneca Pharmaceuticals LP | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| SEAGEN INC. | 1 | $100 |
| Incyte Corporation | 4 | $92 |
| Merck Sharp & Dohme LLC | 5 | $90 |
| BeOne Medicines USA, Inc. | 4 | $89 |
Products named: OPDIVO, Enhertu, KEYTRUDA, EPKINLY, BRUKINSA, Fabhalta, RYBREVANT, Nubeqa.
Industry payments across PA — which companies pay providers there.
